Article Text

Download PDFPDF

‘Our COVID-19 cloud silver lining’: the initiation and progress of postnatal contraception services during the COVID-19 pandemic in a UK maternity hospital
  1. Kate Johanna Campbell1,2,
  2. Rachel Barlow-Evans1,2,
  3. Suzanne Jewell1,2,
  4. Natalie Woodhead2,
  5. Ruchira Singh2,
  6. Kulsum Jaffer1
  1. 1 Sexual Health Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  2. 2 Birmingham Women's Hospital, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
  1. Correspondence to Dr Kate Johanna Campbell, Sexual Health Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham B4 6DH, UK; kate.campbell6{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Key messages

  • Immediate postnatal contraception (PNC) services are convenient and acceptable for postnatal women.

  • Providing immediate PNC is safe and supported by the Faculty of Sexual & Reproductive Healthcare guidance.

  • During the COVID-19 pandemic immediate PNC reduces the need for contact with multiple healthcare providers. This may reduce virus transmission.

The COVID-19 pandemic presented an opportunity to rapidly improve postnatal contraception (PNC) services at the largest single-site maternity unit in the UK, Birmingham Women’s and Children’s Hospital NHS Trust.

Why was change needed?

Prior to March 2020 there was no provision of PNC at the hospital. Midwives would routinely enquire about women’s contraceptive plans and direct them to general practice for advice and initiation. Contraceptive services are free as part of the National Health Service (NHS) to UK residents.

The demand for and importance of PNC provision is well documented. In the UK almost 1 in 13 women presenting for an abortion or delivery has conceived within a year of a previous birth.1 An interpregnancy interval of less than 12 months increases the risk of complications for both mother and baby.2 A 2017 UK survey showed 47% of women would prefer to have their contraception provided from the postnatal ward before discharge.3 A local service evaluation from 2011 highlighted a gap in access to PNC at our hospital and the desire of women to receive both advice and immediate provision.

During March 2020 the COVID-19 pandemic evolved in the UK. Routine health services were disrupted and access to contraception in the community became compromised.4 Birmingham Women’s is a tertiary obstetric hospital caring for all women including those with complex medical needs and high-risk pregnancies. Lack of access to PNC for these women could have grave consequences. They are also at higher risk of adverse outcomes if they contract COVID-195 and many are shielding during the pandemic.

Faculty of Sexual & Reproductive Healthcare (FSRH) guidance states that services providing care to pregnant women should offer all appropriate methods of contraception, including long-acting reversible contraception (LARC), to women before discharge.6 Immediate PNC provision removes the requirement to attend future contraception consultations. During the pandemic this decreases contacts, thereby reducing the risk of viral transmission.

Immediate PNC makes it possible to contact the most vulnerable women, for example, those with substance misuse, mental health problems and language barriers.4 7 Vulnerable women experience more challenges accessing appointments. Women from some ethnic minority backgrounds are at increased risk of serious infection from COVID-19.8

How was change initiated?

Due to the pandemic three Community and Sexual Reproductive Health (CSRH) trainees were redeployed to the hospital. This provided a team with the necessary skills to initiate the service.

The team worked with pharmacy to stock postnatal wards with progestogen-only subdermal implants (POSDIs), progestogen-only injections (POICs) and local anaesthetic. A trolley was stocked with the non-prescription items including a donation of condoms. A patient information leaflet was developed and locally peer reviewed. The team produced posters to raise awareness of the service.

Each morning a CSRH trainee visited the postnatal wards. The service was only staffed during the week and was not able to cover the delivery suite or the midwife-led birth centre. All patients were offered verbal and written information about PNC. A bedside translating service was available. The increased effectiveness of LARC methods was emphasised.9 10 Where possible each woman’s chosen method was provided. Oral contraception was prescribed at the time then dispensed on discharge. POSDIs and POICs were provided during the consultation. In order to minimise potential viral transmission, appropriate personal protective equipment was used and all equipment was cleaned according to local policy. Data were collected prospectively and entered into a secure database.

What was the outcome of the change?

From 1 April to 30 June 2020 a total of 1917 mothers delivered a live birth at the hospital (table 1). Of these, 178 women were discharged directly from the delivery suite and the birth centre, the majority within 6 hours. Twenty-four women had a tubal ligation at the time of delivery. These 202 women were not eligible for our service. Over this period the team worked a total of 56 days and contraception was provided to 453 postnatal women, approximately 26.4% (453/1715) of the eligible postnatal women. Of the 453 postnatal women who initiated contraception, 89 (19.6%) opted for a LARC. One-third (32.2%, 146/453) of the postnatal women who initiated a method were high-risk due to a medical, surgical or social risk factor.

Table 1

Women who delivered at the hospital that were eligible for the service and postnatal women provided with contraception from 1 April to 30 June 2020

From 20 April the team started collecting additional data on the number of postnatal women approached and the number who accepted information on PNC. Figure 1 provides a snapshot of these data from 20 April to 29 June. Over this period the team approached 1029 women and 827 (80.4%) women accepted information; of these, 374 (45.2%) women chose to initiate contraception. Of those who initiated contraception, 75 (20.1%) women accepted a LARC.

Figure 1

Flowchart illustrating contraception uptake in postnatal women from 20 April to 29 June 2020. Key short-acting methods were condoms, the progestogen-only pill and the combined oral contraceptive pill. Long-acting reversible contraception (LARC) methods were progestogen-only subdermal implants and progestogen-only injections.

The team conducted an anonymous paper and online multidisciplinary staff survey. We received 83 responses, of which 82 (99%) respondents felt PNC was important and 72 (87%) felt PNC was extremely important. Seventy-three (88%) respondents believed that PNC should be discussed on the postnatal ward and 52 (63%) felt that it should also be discussed antenatally. Sixty-nine (83%) women were interested or possibly interested in being provided with PNC but only 34 (41%) women were aware which methods could be initiated immediately postpartum.

What lessons were learned?

The response to PNC provision was overwhelmingly positive from women, midwives and obstetricians. We observed a shift towards a “culture of contraception”. Staff initiated conversations with women and then contacted the team to provide an appropriate method. The maternal medicine team directly referred high-risk women whom they had counselled antenatally.

We predicted that uptake would increase with antenatal contraceptive counselling. Women would expect the service, having had time to consider their options. Evidence suggests antenatal contraceptive counselling at around 20–22 weeks’ gestation is acceptable to women and effective.9 10

Women admitted and discharged at weekends were missed, as were those discharged directly from the delivery suite and the birth centre.

A gap in the service was the inability to provide intrauterine contraception (IUC). The team counselled women about where to access IUC and provided a bridging method if this was acceptable to the woman.

How does the future look?

Our ambition is to provide PNC of choice to any woman at any time. The experience of units that have achieved this objective shows us that we need to strengthen antenatal contraceptive counselling, initiate immediate postpartum IUC, and improve provision of postpartum methods by ensuring there are enough providers to deliver the contraception required.9 10 We need collaboration between the hospital, local sexual health services and primary care. Discussions to secure funding of an ongoing service are underway between commissioners.

Throughout the pandemic our team has provided contraceptive teaching to obstetric and midwifery colleagues via opportunistic face-to-face education and has organised small group or virtual sessions. Additionally, midwife-specific e-learning is being developed and we have started POSDI insertion training. A patient group direction allowing non-prescribers to provide oral desogestrel 75 μg has been written. A standard operating procedure for immediate insertion of IUC at caesarean section and follow-up pathway is awaiting ratification. We plan to then progress to insertion of IUC at vaginal delivery.

Our PNC COVID-19 service has been a great success at a challenging time. We have developed a better way of working and we are determined to make it even better.

Ethics statements



  • Contributors KJC: primary author and data collection. RBE: data analysis and data collection. SJ: data collection. NW: proofreading and editing. RS: concept, final proofreading. KJ: concept.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer reviewed.